BCID2 Panel Significantly Reduces Time to Appropriate Therapy in Gram-Negative BSIs

Implementation of the BioFire FilmArray BCID2 (bioMérieux) resulted in clinically significant reduced time ...

AUGUST 6, 2025

New Delhi Metallo-Beta-Lactamase Cases Rise in NYC

NDM-positive carbapenem-resistant Enterobacterales cases have been increasing in New York City. 

JULY 31, 2025

Increased Incidence of CRE Reports Due to Definition Change

The prevalence of carbapenem-resistant Enterobacteriaceae (CRE) increased by nearly threefold between 2015 and ...

NOVEMBER 27, 2018

The War on (Antimicrobial) Drugs: The Fight Against Superbugs

What is a superbug, and why should we as physicians and health care providers be worried?

MAY 30, 2018

Investigational Relebactam Plus Imipenem-Cilastatin Effective Against CRE

A new antimicrobial combination appears effective and safe against CRE.

APRIL 24, 2018

CDC Program Tries to Put Out Spark Before Resistance Spreads ‘Like Wildfire’

Ramped-up CDC strategy helps providers stop spread of new resistant organisms, prevents large outbreaks.

APRIL 3, 2018

Phantom Menace Increasingly Prevalent in U.S. Hospitals

Although not yet associated with outbreaks in the United States, carbapenem-resistant Enterobacteriaceae are ...

MARCH 27, 2018

High Prevalence of CRE in D.C. Health Care Facilities

Colonization can be a predictor for future infections and outbreaks, so it is important for health care ...

JUNE 28, 2017

First U.S. Death From Pan-Resistant Superbug Reported

The CDC reported the first death from carbapenem-resistant Enterobacteriaceae (CRE) that was resistant to all ...

JANUARY 17, 2017